Open AccessShort-time interruption of second-line mycophenolate treatment in a patient with renal sarcoidosis enabled a marked antibody response to SARS-CoV-2 messenger RNA vaccine
Author(s) -
Peter Schnuelle,
Sebastian Kölling,
Alexander Müller,
Wilhelm H. Schmitt
Publication year - 2021
Publication title -
clinical kidney journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 40
eISSN - 2048-8513
pISSN - 2048-8505
DOI - 10.1093/ckj/sfab289
Subject(s) - medicine , sarcoidosis , covid-19 , virology , messenger rna , antibody , dolutegravir , immunology , virus , disease , infectious disease (medical specialty) , gene , biochemistry , antiretroviral therapy , viral load , outbreak , chemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom